LIVALO pitavastatin 2 mg film-coated tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

pitavastatin calcium, Quantity: 2.09 mg (Equivalent: pitavastatin, Qty 2 mg)

Available from:

Advantage Medical Products Consulting Pty Ltd

INN (International Name):

pitavastatin calcium

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: colloidal anhydrous silica; triethyl citrate; aluminium magnesium silicate; magnesium stearate; lactose monohydrate; hypromellose; titanium dioxide; hyprolose

Administration route:

Oral

Units in package:

28, 10, 30, 100

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Product summary:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '2' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2013-08-27